PL3006027T3 - Kompozycje zawierające aminokwasy do stosowania w leczeniu ogólnoustrojowego stanu zapalnego związanego z udarem u pacjentów z dysfagią - Google Patents
Kompozycje zawierające aminokwasy do stosowania w leczeniu ogólnoustrojowego stanu zapalnego związanego z udarem u pacjentów z dysfagiąInfo
- Publication number
- PL3006027T3 PL3006027T3 PL15187946T PL15187946T PL3006027T3 PL 3006027 T3 PL3006027 T3 PL 3006027T3 PL 15187946 T PL15187946 T PL 15187946T PL 15187946 T PL15187946 T PL 15187946T PL 3006027 T3 PL3006027 T3 PL 3006027T3
- Authority
- PL
- Poland
- Prior art keywords
- dysphagia
- patients
- stroke
- compositions
- treatment
- Prior art date
Links
- 208000019505 Deglutition disease Diseases 0.000 title 1
- 206010061218 Inflammation Diseases 0.000 title 1
- 208000006011 Stroke Diseases 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 title 1
- 230000004054 inflammatory process Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000009885 systemic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITTO20140806 | 2014-10-08 | ||
| EP15187946.7A EP3006027B1 (en) | 2014-10-08 | 2015-10-01 | Compositions comprising amino acids for use in the treatment of systemic inflammation state associated to stroke in patients with dysphagia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3006027T3 true PL3006027T3 (pl) | 2018-02-28 |
Family
ID=52101507
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15187946T PL3006027T3 (pl) | 2014-10-08 | 2015-10-01 | Kompozycje zawierające aminokwasy do stosowania w leczeniu ogólnoustrojowego stanu zapalnego związanego z udarem u pacjentów z dysfagią |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9707198B2 (pl) |
| EP (1) | EP3006027B1 (pl) |
| JP (1) | JP6447716B2 (pl) |
| KR (1) | KR102077374B1 (pl) |
| AU (1) | AU2015329581B2 (pl) |
| CA (1) | CA2958033C (pl) |
| DK (1) | DK3006027T3 (pl) |
| ES (1) | ES2651903T3 (pl) |
| HU (1) | HUE035699T2 (pl) |
| NO (1) | NO3006027T3 (pl) |
| NZ (1) | NZ728962A (pl) |
| PL (1) | PL3006027T3 (pl) |
| RU (1) | RU2668373C1 (pl) |
| WO (1) | WO2016055948A1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016181335A1 (en) * | 2015-05-14 | 2016-11-17 | Professional Dietetics S.P.A. | Compositions comprising amino acids for use in the treatment of mucositides in neoplasia patients undergoing radiation therapy and/or chemotherapy |
| IT201700087376A1 (it) * | 2017-07-28 | 2019-01-28 | Professional Dietetics Spa | Composizioni comprendenti amino acidi per l'uso nel trattamento di malattie associate a disfunzione mitocondriale |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4780475A (en) * | 1986-02-03 | 1988-10-25 | Cerra Frank B | Preparation for the prevention of catabolism |
| US5276018A (en) * | 1992-07-17 | 1994-01-04 | Brigham And Women's Hospital | Composition comprising amino acids and methods for decreasing muscle breakdown |
| IT1320783B1 (it) * | 2000-07-04 | 2003-12-10 | Professional Dietetics Srl | Composizioni a base di aminoacidi, atte al miglioramento delleprestazioni muscolari. |
| US20030060421A1 (en) * | 2001-07-19 | 2003-03-27 | Neuron Therapeutics, Inc. | Kits and compositions supporting intracranial perfusions |
| EP2275084A1 (en) * | 2009-07-15 | 2011-01-19 | Unilever PLC | Oral care composition |
| CN102647990A (zh) * | 2009-07-20 | 2012-08-22 | 雀巢产品技术援助有限公司 | 减少功能状态损失的方法 |
| CA2825839C (en) * | 2011-03-01 | 2021-01-12 | Nestec S.A. | Extensional viscosity to promote safe swallowing of food boluses |
| JP5837315B2 (ja) * | 2011-03-25 | 2015-12-24 | イーエヌ大塚製薬株式会社 | 炎症性疾患用栄養組成物 |
| WO2012133198A1 (ja) * | 2011-03-25 | 2012-10-04 | イーエヌ大塚製薬株式会社 | 炎症性疾患用栄養組成物 |
| JP2012214451A (ja) * | 2011-03-25 | 2012-11-08 | En Otsuka Pharmaceutical Co Ltd | 炎症性疾患用アミノ酸組成物 |
| WO2012142678A1 (en) * | 2011-04-21 | 2012-10-26 | Fit-Bioceuticals Limited | Weight loss composition |
| RU2526826C2 (ru) * | 2012-10-24 | 2014-08-27 | Николай Владимирович Соловьёв | Композиция для парентерального введения, способ получения и применение композиции |
-
2015
- 2015-10-01 PL PL15187946T patent/PL3006027T3/pl unknown
- 2015-10-01 EP EP15187946.7A patent/EP3006027B1/en active Active
- 2015-10-01 DK DK15187946.7T patent/DK3006027T3/en active
- 2015-10-01 ES ES15187946.7T patent/ES2651903T3/es active Active
- 2015-10-01 HU HUE15187946A patent/HUE035699T2/en unknown
- 2015-10-01 NO NO15187946A patent/NO3006027T3/no unknown
- 2015-10-07 NZ NZ728962A patent/NZ728962A/en unknown
- 2015-10-07 AU AU2015329581A patent/AU2015329581B2/en active Active
- 2015-10-07 CA CA2958033A patent/CA2958033C/en active Active
- 2015-10-07 JP JP2017511782A patent/JP6447716B2/ja active Active
- 2015-10-07 WO PCT/IB2015/057662 patent/WO2016055948A1/en active Application Filing
- 2015-10-07 RU RU2017112492A patent/RU2668373C1/ru active
- 2015-10-07 KR KR1020177009224A patent/KR102077374B1/ko active IP Right Grant
- 2015-10-08 US US14/878,100 patent/US9707198B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20160101078A1 (en) | 2016-04-14 |
| EP3006027B1 (en) | 2017-11-15 |
| CA2958033A1 (en) | 2016-04-14 |
| RU2668373C1 (ru) | 2018-09-28 |
| HUE035699T2 (en) | 2018-05-28 |
| DK3006027T3 (en) | 2017-12-18 |
| CA2958033C (en) | 2019-07-16 |
| US9707198B2 (en) | 2017-07-18 |
| KR20170057308A (ko) | 2017-05-24 |
| AU2015329581B2 (en) | 2019-02-07 |
| JP6447716B2 (ja) | 2019-01-09 |
| AU2015329581A1 (en) | 2017-03-02 |
| ES2651903T3 (es) | 2018-01-30 |
| EP3006027A1 (en) | 2016-04-13 |
| KR102077374B1 (ko) | 2020-02-13 |
| JP2017530103A (ja) | 2017-10-12 |
| WO2016055948A1 (en) | 2016-04-14 |
| NO3006027T3 (pl) | 2018-04-14 |
| NZ728962A (en) | 2019-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1232160A1 (zh) | 脂肪酸及其於共軛至生物分子之用途 | |
| IL252596A0 (en) | History of azabicyclooctane as fxr agonists for use in the treatment of liver and gastrointestinal diseases | |
| HK1222097A1 (zh) | 用於吞嚥困難患者的營養的組合物 | |
| HK1222552A1 (zh) | 索布替羅用於治療髓鞘形成疾病 | |
| IL280690A (en) | Pharmaceutical preparations that include DGLA and their use | |
| GB201404403D0 (en) | Compositions and methods relating to the treatment of diseases | |
| PL2964215T3 (pl) | Mieszanina kwasów tłuszczowych do zastosowania do leczenia patologicznych stanów zapalnych | |
| HK1221960A1 (zh) | 用於治療口腔粘膜炎的新型肽和類似物 | |
| IL246855A0 (en) | Materials for use in the treatment of retinitis | |
| HK1225994A1 (zh) | 用於治療過敏性病症的組合物 | |
| IL251345A0 (en) | Preparations for use in the treatment of peri-implantitis | |
| PL3006027T3 (pl) | Kompozycje zawierające aminokwasy do stosowania w leczeniu ogólnoustrojowego stanu zapalnego związanego z udarem u pacjentów z dysfagią | |
| FI3397270T3 (fi) | Koostumuksia käytettäväksi Hunterin oireyhtymän hoidossa | |
| TH1401007652A (th) | อะมิโนไตรอะโซโลไพริดีนสำหรับการใช้ในการรักษาการอักเสบ และองค์ประกอบทางเภสัชกรรมของมัน |